Kevin Charles Gorman, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 292,210 shares at $149.46 ($43.7M) on 2025-01-27, disclosed to the SEC on 2025-01-29.
Scheduled sale ($43.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.46 | 146,105 | $21.8M | 50.0% |
| 2 | $149.46 | 146,105 | $21.8M | 50.0% |
| Total | $149.46 avg | 292,210 | $43.7M | 100% |
| Filing → |
| NBIX | SELL | 2025-08-11 | $26.9M | — | Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |